Cargando…
Systemic Steroids in Preventing Bronchopulmonary Dysplasia (BPD): Neurodevelopmental Outcome According to the Risk of BPD in the EPICE Cohort
Background: Postnatal steroids (PNS) have been used to prevent bronchopulmonary dysplasia (BPD) in preterm infants but have potential adverse effects on neurodevelopment. These effects might be modulated by their risk of BPD. We aimed to compare patients’ neurodevelopment with PNS treatment accordin...
Autores principales: | Zayat, Noura, Truffert, Patrick, Drumez, Elodie, Duhamel, Alain, Labreuche, Julien, Zemlin, Michael, Milligan, David, Maier, Rolf F., Jarreau, Pierre-Henri, Torchin, Héloïse, Zeitlin, Jennifer, Nuytten, Alexandra, , on behalf of the EPICE Research Group |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106050/ https://www.ncbi.nlm.nih.gov/pubmed/35564997 http://dx.doi.org/10.3390/ijerph19095600 |
Ejemplares similares
-
BPD, Not BPD, or Iatrogenic BPD: Findings of Lung Ultrasound Examinations
por: Liu, Jing, et al.
Publicado: (2014) -
Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms
por: Chen, Xin, et al.
Publicado: (2019) -
Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
por: Omar, Said A., et al.
Publicado: (2022) -
Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice
por: Das, Pragnya, et al.
Publicado: (2021) -
Bronchopulmonale Dysplasie (BPD)
por: Herting, E.
Publicado: (2013)